This cross-functional course focuses on ‘real-world’ issues for commercializing pharmaceutical drugs in a rapidly changing and complex global business environment. This course will highlight the influential role external stakeholders (governments, regulators, payers, purchasing organizations, hospitals, physicians, pharmacies, patients, care givers and advocacy groups) and internal functions (early development, late stage development, data management, manufacturing, medical affairs, market access and commercial teams) play along a brand’s lifecycle, driving commercial success. Key topics to be explored include:
- Market dynamics, competitive strategies, clinical practices, regulatory issues, access challenges and lifecycle planning
- Internal and external stakeholders who influence the commercialization of the brand
- Brand strategy plans, brand forecasts, inputs into strategic clinical development options, science and communications strategies
- Strategies for pricing, market access and reimbursement in multiple geographies
Students who are interested in gaining insight into this increasingly complex market environment, and desire to learn how to navigate the influencers and set the stage for commercialization of pharmaceuticals, will benefit from the curriculum. This course will assist students interested in careers in pharmaceuticals, biotechnology, and healthcare, as well as management consulting and the financial industry, given the large and growing pharmaceutical practices of such firms.
M. Jamil is a results-oriented pharmaceutical leader with two decades of strategic and operational experience in complex, cross-geo operations of matrix organizations. Jamil is passionate about leading high-functioning team and using technology (biology & digital) to improve and extend lives of cancer patients. Jamil is currently working at Merck & Co to help commercialize an immunotherapy product. Previously he had worked in marketing...